{"id":20756,"date":"2015-01-30T21:14:44","date_gmt":"2015-01-30T18:14:44","guid":{"rendered":"https:\/\/sfee.gr\/?p=20756"},"modified":"2015-04-20T17:50:57","modified_gmt":"2015-04-20T14:50:57","slug":"transparency-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.sfee.gr\/en\/transparency-in-clinical-trials\/","title":{"rendered":"Transparency in Clinical Trials"},"content":{"rendered":"

This webpage refers to the electronic Registry of Non-Interventional Studies (RNIS)<\/strong> and is posted on the website of the Hellenic Association of Pharmaceutical Companies (SFEE)<\/strong>. It is an integral part of the SFEE Code of Ethics (the \u201cCode\u201d)<\/strong> as amended by the SFEE General Assembly on 08.03.2013 and in effect as from 08.03.2013.<\/p>\n

The Code<\/strong> aims to harmonise practices across the pharmaceutical industry in terms of transparency, ethics and professional conduct<\/strong>.<\/p>\n

The Registry includes all registered Non-Interventional Studies<\/strong> (EMA annex March 2011) which are being conducted by SFEE member companies and admit subjects as from 1 January 2013. In these studies, a medicinal product is prescribed<\/strong> in accordance with usual clinical practice and its marketing authorisation. In addition, the Registry includes a second category of studies that do not involve medicinal products, i.e. epidemiologic observational studies<\/strong>.<\/p>\n

Specifically, the following data are recorded<\/strong> in the Registry and made publicly available:<\/strong><\/p>\n